PBMCs were separated by Histopaque-1077® (Sigma-Aldrich, St. Louis, MO, USA) density centrifugation following the manufacturer's instructions. Monocytes were isolated by positive selection with anti-CD14 magnetic beads using the MACS cell separation system (Miltenyi Biotec, Cologne, Germany).
CD14+ cells were used after purification (monocytes) or to promote differentiation in dendritic cells by plating them at 106 cells/mL in RPMI 10% iFBS supplemented with 50 ng/mL of IL-4 and GM-CSF (ImmunoTools, Friesoythe, Germany). After 7 days, monocyte-derived dendritic cells (Mo-DCs) were collected and used for lipid antigen presentation assays.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.